drugset / Trial / NCT01571063

Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin D

NCT01571063

Phase 2 Completed 22 enrolled University of Zurich
RandomizedSingle-groupQuadruple-blindTreatment

Summary

Test the efficacy of vitamin D to improve non-alcoholic steatohepatitis with regard to biochemical and histological parameters. * Trial with medicinal product

Timeline

Start
2013-01
Primary completion
2016-05
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 2100 iu Oral